Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05408975 · ClinicalTrials.gov registry record · NA

Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS)

A NA study of Traumatic Brain Injury and Cognitive Change, sponsored by The University of Texas at Dallas.

Completed
Registry status
NA
Development phase
5
Enrollment target
2
Study locations

NCT05408975: Completed NA study of Traumatic Brain Injury and Cognitive Change, sponsored by The University of Texas at Dallas.

NCT05408975 is a NA study of Traumatic Brain Injury and Cognitive Change that has completed, run by The University of Texas at Dallas. The registered enrollment target is 5 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05408975, a NA study of Traumatic Brain Injury and Cognitive Change, has completed, sponsored by The University of Texas at Dallas.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought to aid in memory will improve verbal retrieval in civilian (non-military, non-veteran) participants with histories of traumatic brain injuries. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition, concussion history, structural brain imaging, and EEG predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.

Primary Outcome

Evaluation of treatment differences (active versus sham) in change on the Control Word Association Test. Metric: Total Number of Correct Items Generated for three different letters. Total Range 0 (minimum) - 200 (maximum). Larger numbers indicate better performance.

Interventions

  • DEVICE Active Transcranial direct current stimulation
  • DEVICE Sham Transcranial direct current stimulation

Study Locations (2)

Texas

  • The University of Texas at Dallas - Dallas
  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2023-01-01
Est. Completion 2024-11-30
Phase NA
The University of Texas at Dallas

50 total trials

What the finished NCT05408975 record still lists

NCT05408975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Active Transcranial direct current stimulation is the first listed.

NCT05408975 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05408975 about?

NCT05408975 is a clinical study titled "Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS)". The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought to aid in memory will improve verbal retrieval in civilian (non-military, non-veteran) participants...

What is the current status of trial NCT05408975?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2023-01-01. Estimated completion is 2024-11-30.

What conditions does trial NCT05408975 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Cognitive Change, Acquired Brain Injury, Word Finding Difficulty.

What interventions are being tested in trial NCT05408975?

The interventions under investigation include: Active Transcranial direct current stimulation (DEVICE), Sham Transcranial direct current stimulation (DEVICE).

Who is sponsoring clinical trial NCT05408975?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05408975 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05408975's enrollment target sits among peer trials

5 169th of 171 higher than 2 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05408975, the US trial registry maintained by the National Library of Medicine. NCT05408975 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.